Literature DB >> 1960541

The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer.

G Cavaletti1, G Bogliun, L Marzorati, M Marzola, M R Pittelli, G Tredici.   

Abstract

Sensorimotor polyneuropathy is the most common of the paraneoplastic syndromes involving the nervous system. Its incidence is high (more than 50%) in the patients undergoing neurophysiological investigation, and it is considered to be more frequent in subjects with lung and breast cancers. In this study we evaluated a series of 58 women with epithelial ovarian cancer at FIGO stages I and III. The aim of the study was to assess the incidence and characteristics of peripheral nerve involvement during the course of the disease both clinically and neurophysiologically. Our results suggest that in women with epithelial ovarian cancer (1) the incidence of subclinical polyneuropathy is high; (2) sensory involvement is predominant in stage I, but motor involvement is frequent in stage III; and (3) the incidence of peripheral nerve involvement increases with progression of the cancer.

Entities:  

Mesh:

Year:  1991        PMID: 1960541     DOI: 10.1007/bf00319854

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Peripheral neuropathy and myopathy associated with carcinoma of the lung.

Authors:  W Trojaborg; E Frantzen; I Andersen
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

2.  The course and prognosis in some types of carcinomatous neuromyopathy.

Authors:  P B Croft; M Wilkinson
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

3.  Peripheral neuropathy of sensorimotor type associated with malignant disease.

Authors:  P B Croft; H Urich; M Wilkinson
Journal:  Brain       Date:  1967-03       Impact factor: 13.501

4.  Carcinomatous neuromuscular syndromes. A clinical and quantitative electrophysiological study.

Authors:  T Paul; B C Katiyar; S Misra; G C Pant
Journal:  Brain       Date:  1978-03       Impact factor: 13.501

5.  Peripheral nerve function in patients with bronchial carcinoma. Comparison with matched controls and effects of treatment.

Authors:  J A Lenman; A M Fleming; M A Robertson; R J Abbott; M D Clee; I F Ferguson; D S Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

6.  Hypothyroidism and polyneuropathy.

Authors:  E Beghi; M L Delodovici; G Bogliun; V Crespi; F Paleari; P Gamba; M Capra; M Zarrelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

7.  Subacute sensory neuropathy: a remote effect of carcinoma.

Authors:  M S Horwich; L Cho; R S Porro; J B Posner
Journal:  Ann Neurol       Date:  1977-07       Impact factor: 10.422

8.  Carcinomatous neuromyopathy. 1. Electrophysiological studies. An electrophysiological and immunological study of patients with carcinoma of the lung.

Authors:  M J Campbell; D W Paty
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-02       Impact factor: 10.154

9.  Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.

Authors:  P J Dyck; W R Sherman; L M Hallcher; F J Service; P C O'Brien; L A Grina; P J Palumbo; C J Swanson
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

10.  Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms.

Authors:  H R Brashear; J E Greenlee; K A Jaeckle; J W Rose
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

View more
  5 in total

1.  Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study.

Authors:  Roberto Meroni; Paola Alberti; Paola Boria; Simone Giordano; Guido Cavaletti
Journal:  Int Arch Occup Environ Health       Date:  2017-06-20       Impact factor: 3.015

2.  Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Authors:  Paola Alberti; Emanuela Rossi; Andreas A Argyriou; Haralabos P Kalofonos; Chiara Briani; Mario Cacciavillani; Marta Campagnolo; Jordi Bruna; Roser Velasco; Marina E Cazzaniga; Diego Cortinovis; Maria G Valsecchi; Guido Cavaletti
Journal:  Support Care Cancer       Date:  2018-03-29       Impact factor: 3.603

3.  Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Authors:  G Bogliun; L Marzorati; G Cavaletti; L Frattola
Journal:  Ital J Neurol Sci       Date:  1992-11

Review 4.  Comparative adverse effect profiles of platinum drugs.

Authors:  M J McKeage
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

5.  Endometrial carcinoma presenting as vasculitic sensorimotor polyneuropathy.

Authors:  Marketa Vasku; Thomas Papathemelis; Nicolai Maass; Ivo Meinhold-Heerlein; Dirk Bauerschlag
Journal:  Case Rep Obstet Gynecol       Date:  2011-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.